Ole S. Søgaard

ORCID: 0000-0001-9107-2023

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 18 papers. Top paper: “Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial”.

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Nature Medicine(2022)10.1038/s41591-022-02023-7

N/A

2.7DataRank · unranked

141 citations

Marie H. Pahus, Míriam Rosás-Umbert, I‐Na Lu, Thomas Benfield, Henrik Nielsen +28 more

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

Nature Medicine(2023)10.1038/s41591-023-02547-6

N/A

1.6DataRank · unranked

85 citations

Jesper Falkesgaard Højen, Marie H. Pahus, Míriam Rosás-Umbert, Birgitte Stiksrud, James McMahon +28 more

A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste

medRxiv(2022)10.1101/2022.01.28.22270035

N/A

1.4DataRank · unranked

27 citations

Anne Spichler-Moffarah, Ole S. Søgaard, Denise Esserman, James Dziura, Lisa Danzig +19 more

Nanobody‐mediated complement activation to kill HIV‐infected cells

EMBO Molecular Medicine(2023)10.15252/emmm.202216422

N/A

0.406DataRank · unranked

14 citations

Dennis Pedersen, Mikael Winkler, Heidi Gytz Olesen, Ole S. Søgaard, Lars Østergaard +4 more

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control

Nature Immunology(2026)10.1038/s41590-026-02448-z

N/A

0.330DataRank · unranked

8 citations

Mauro A. Garcia, Giacomo S. Frattari, Chloé Naasz, Junlin Zhuo, Míriam Rosás-Umbert +37 more

Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti–HIV-1 Antibodies

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae486

N/A

0.269DataRank · unranked

5 citations

Yu Zheng, Maxine Olefsky, Jesper Damsgaard Gunst, Pablo Tebas, Babafemi Taiwo +8 more

The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection

Journal of Interferon & Cytokine Research(2021)10.1089/jir.2021.0106

N/A

0.208DataRank · unranked

3 citations

Ida Monrad, Line K. Vibholm, Stine Sofie Frank Nielsen, Giacomo S. Frattari, Mariane Høgsbjerg Schleimann +8 more

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: An individual data-based meta-analysis of 24 prospective studies

Research Square(2024)10.21203/rs.3.rs-5065764/v1

N/A

0.104DataRank · unranked

1 citations

Jesal Gohil, Jonathan Z. Li, Ronald J. Bosch, Andrea J. White, Catherine Seamon +26 more

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Nature Medicine(2021)10.1038/s41591-021-01590-5

N/A

0DataRank · unranked

372 citations

Nancie M. Archin, Paula M. Cannon, Simon Collins, R. Brad Jones, Marein A.W.P. de Jong +74 more

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

EBioMedicine(2021)10.1016/j.ebiom.2021.103255

N/A

0DataRank · unranked

401 citations

Heike Hofmann-Winkler, Joan C. Smith, Nadine Krüger, Prerna Arora, Lambert K. Sørensen +18 more

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity

Scientific Reports(2024)10.1038/s41598-024-65576-2

N/A

0DataRank · unranked

5 citations

Maia M. C. Bennett-Boehm, Frederik Holm Rothemejer, I. Weber, Alexander K. Regan, J. Franzen +11 more

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies

Nature Communications(2025)10.1038/s41467-025-56116-1

N/A

0DataRank · unranked

55 citations

Jesal Gohil, Jonathan Z. Li, Ronald J. Bosch, Caitlin White, Tae‐Wook Chun +25 more

TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets

Vaccine(2025)10.1016/j.vaccine.2025.127851

N/A

0DataRank · unranked

2 citations

Anna Halling Folkmar Rahimic, Giacomo S. Frattari, Míriam Rosás-Umbert, Mariane Høgsbjerg Schleimann, Rikke Olesen +5 more

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial

medRxiv(2025)10.1101/2025.11.03.25339415

N/A

0DataRank · unranked

7 citations

Anna Kaczynska, Marius Allombert, Ágata Lopes-Ribeiro, Mariângela de Oliveira Silva, Brianna J. Hernandez +30 more

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Nature Communications(2022)10.1038/s41467-022-34171-2

N/A

0DataRank · unranked

98 citations

Jesper Damsgaard Gunst, Marie H. Pahus, Rikke Olesen, Mariane Høgsbjerg Schleimann, Paul W. Denton +17 more

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.05.237651

N/A

0DataRank · unranked

80 citations

Heike Hofmann-Winkler, Joan C. Smith, Nadine Krüger, Lambert K. Sørensen, Ole S. Søgaard +14 more

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome

EBioMedicine(2022)10.1016/j.ebiom.2022.103956

N/A

0DataRank · unranked

14 citations

Anna Esteve‐Codina, María Berdasco, Míriam Rosás-Umbert, Eléna Gonçalves, Clara Duran-Castells +21 more

Nanobody-mediated Complement Activation to Kill HIV-infected Cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.09.495439

N/A

0DataRank · unranked

1 citations

Dennis Pedersen, Mikael Winkler, Heidi Gytz Olesen, Ole S. Søgaard, Lars Østergaard +4 more